
Could Montelukast Be a Key to Managing GI Side Effects of Tecfidera?
Chris Tanski received his PharmD from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and is now working as a clinical staff pharmacist for Pinnacle Health in Harrisburg, Pennsylvania. He entered the field of hospital pharmacy directly from school, and he was one of the first to pilot a decentralized pharmacist role in the hospital. His other notable work contributions include working on palliative projects and transition of care for COPD patients. Chris was an editor and contributor to a film theory blog, a sketch comedy writer throughout pharmacy school, and he has a significant amount of experience writing drug information papers on neurology and infectious disease topics for both school and work.
Could Montelukast Be a Key to Managing GI Side Effects of Tecfidera?
Ocrevus is the first medication approved for primary-progressive MS. Here's what you should know.
What are the best practice considerations for managing Parkinson's Psychosis?
The first new FDA approval for ALS in 22 years, here's what you should know.
Published: May 10th 2017 | Updated:
Published: May 8th 2017 | Updated:
Published: May 30th 2017 | Updated:
Published: August 14th 2017 | Updated: